Atyr Pharma Inc share price logo

Atyr Pharma Inc Share Price

NASDAQ: ATYR

Small Cap

$1.01

-5.02

(-83.17%)

as on

Atyr Pharma Inc Stock Performance

as on September 16, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $1
    $1.37
    downward going graph

    0.99%

    Downside

    35.64%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.67
    $7.29
    downward going graph

    -65.35%

    Downside

    621.82%

    Upside

    downward going graph

Atyr Pharma Inc share price movements today

Previous Close
$6.03
Open
$1.20
Volume
143.3M
Day's Low - High
$1 - $1.37
52 Week Low - High
$1.67 - $7.29

Atyr Pharma Inc Historical Returns

1 Month Return
+ 23.06 %
3 Month Return
+ 15.96 %
1 Year Return
+ 217.37 %
3 Year Return
0 %
5 Year Return
0 %

Atyr Pharma Inc Stock Fundamentals & Key Indicators

Check Atyr Pharma Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$590.9M

EPS (TTM)

-0.6673

Dividend Yield

0.00%

PE Ratio (TTM)

-2.47

Industry PE ratio

0

P/B Ratio

0

PEG Ratio

0

Return On Equity TTM

83400.00%

Atyr Pharma Inc Stock Valuation

Track how Atyr Pharma Inc P/E has moved over time to understand its valuation trends.

Atyr Pharma Inc in the last 5 years

  • Overview

  • Trends

Lowest (0.00x)

September 15, 2025

Industry (0.00x)

September 15, 2025

Today (-2.47x)

September 15, 2025

Highest (0.00x)

September 15, 2025

LowHigh

Today’s Price to Earnings Ratio: -2.47x

Atyr Pharma Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Atyr Pharma Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
NA$590.9MNA-2.470.00%
BUY$61.1B256.98%-505.15-12.96%
NA$38.7BNANA-3.89%
BUY$101.1B47.85%28.0731.86%
BUY$59.4B-3.43%14.1131.37%

Stock Returns calculator for Atyr Pharma Inc Stock including INR - Dollar returns

The Atyr Pharma Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

Atyr Pharma Inc investment value today

Current value as on today

₹58,143

Returns

₹41,857

(-41.86%)

Returns from Atyr Pharma Inc Stock

₹46,842 (-46.84%)

Dollar Returns*

₹4,985 (+4.99%)

Atyr Pharma Inc Stock's Interest Amongst Investors

Investment in Atyr Pharma Inc Shares on INDmoney has dropped by -51.72% over the past 30 days, indicating reduced transactional activity.

Time period: to

Change:-51.72% versus previous 30 day period

Search interest for Atyr Pharma Inc Stock has increased by 3% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:3% versus previous 30 day period

Atyr Pharma Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
-
-
0
-
0
-
-
-
-
-
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
-12
-13
-12
-15
-16
-17
-18
-15
-15
-20
EBITDA
-12
-12
-11
-15
-15
-16
-17
-15
-15
-20
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-11
-12
-11
-14
-15
-16
-17
-14
-14
-19
Income Tax Expense
0
0
0
0
0
0
-
-
-
-
Net Income
-11
-12
-11
-14
-15
-16
-17
-14
-14
-19
Net Profit Margin
0.00%
0.00%
-3212.46%
0.00%
-6591.91%
0.00%
0.00%
0.00%
0.00%
0.00%

Atyr Pharma Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
0
10
-
10
0
0
Gross Profit
-13
-6
-1
8
0
0
Operating Income
-22
-15
-34
-46
-54
-67
EBITDA
-21
-14
-32
-44
-52
-66
Interest Expense
-
-
-
-
-
-
Depreciation
-
1
1
1
2
1
Income Before Tax
-23
-16
-33
-45
-50
-64
Income Tax Expense
0
0
0
0
0
-
Net Income
-23
-16
-33
-45
-50
-64
Net Profit Margin
-5593.13%
-155.18%
0.00%
-436.53%
-14274.50%
-27243.83%

Atyr Pharma Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-12
-11
-14
-15
-16
-17
-14
-14
-19
Operating Cash Flow
-12
-9
-11
-22
-20
-13
-13
-15
-13
Investing Cash Flow
-4
4
17
-1
6
17
-6
-4
3
Financing Cash Flow
8
2
6
7
13
0
18
18
17
Change in Cash
-8
-2
12
-15
0
4
0
-1
7

Atyr Pharma Inc Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-57
-48
-34
-23
-16
-33
-45
-50
-64
Operating Cash Flow
-52
-42
-31
-20
-15
-33
-41
-33
-69
Investing Cash Flow
33
-27
37
4
6
-91
47
-20
17
Financing Cash Flow
4
52
-4
1
16
110
5
66
39
Change in Cash
-14
-17
1
-13
7
-14
10
12
-12

Atyr Pharma Inc News & Key Events

  • img

    Today's Timeline - 15 September

    Mon, 08:28 PM

    -

    Atyr Pharma stock plummets 80.76% after Phase 3 trial fails primary endpoint for efzofitimod in pulmonary sarcoidosis.

Insights on Atyr Pharma Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, ATYR stock has moved up by 13.6%

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, ATYR has outperformed top 5 stocks with highest market-cap in its industry

About Atyr Pharma Inc

atyr pharma (nasdaq: life) is engaged in the discovery and clinical development of innovative medicines for patients suffering from severe rare diseases using its knowledge of physiocrine biology, a newly discovered set of physiological modulators. the company's lead candidate, resolaris™, is a first-in-class intravenous protein therapeutic for the treatment of rare myopathies with an immune component. resolaris is currently in a phase 1b/2 clinical trial in adult patients with facioscapulohumeral muscular dystrophy (fshd); a phase 1b/2 trial in adult patients with limb girdle muscular dystrophy (lgmd) 2b or fshd; and a phase 1b/2 trial in patients with an early onset form of fshd. to protect this pipeline, atyr built an intellectual property estate comprising 70 issued or allowed patents and over 240 pending patent applications that are solely owned or exclusively licensed by atyr. atyr's key programs are currently focused on severe, rare diseases characterized by immune dysregulation
OrganisationAtyr Pharma Inc
Headquarters10240 Sorrento Valley Road, San Diego, CA, United States, 92121
CEODr. Sanjay S. Shukla M.D., M.S.
E-voting on sharesClick here to vote

Key Management of Atyr Pharma Inc

Name

Title

Dr. Leslie Nangle Ph.D.

Vice President of Research

Dr. Sanjay S. Shukla M.D., M.S.

President, CEO & Director

Ms. Nancy E. Denyes Krueger J.D.

General Counsel & Corporate Secretary

Dr. Jayant Aphale MBA, Ph.D.

Vice President of Technical Operations

Ms. Ashlee Dunston

Director of Investor Relations & Corporate Communications

Mr. Peter Villiger

Vice President of Corporate Development

Ms. Danielle Campbell

VP of Human Resource

Ms. Dalia R. Rayes M.B.A.

Head of Commercial, Global Efzofitimod Franchise

FAQs

What is Atyr Pharma Inc share price today?

Atyr Pharma Inc share price today is $1.01 as on at the close of the market. Atyr Pharma Inc share today touched a day high of $1.37 and a low of $1.

What is the 52 week high and 52 week low for Atyr Pharma Inc share?

Atyr Pharma Inc share touched a 52 week high of $7.29 on and a 52 week low of $1.67 on . Atyr Pharma Inc stock price today i.e. is closed at $1.01,which is 86.15% down from its 52 week high and -39.52% up from its 52 week low.

What is Atyr Pharma Inc's market capitalisation today?

Atyr Pharma Inc market capitalisation is $0.00T as on .

How to invest in Atyr Pharma Inc Stock (ATYR) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Atyr Pharma Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Atyr Pharma Inc Shares that will get you 1.4851 shares as per Atyr Pharma Inc share price of $1.01 per share as on September 16, 2025 at 1:29 am IST.

What is the minimum amount required to buy Atyr Pharma Inc Stock (ATYR) from India?

Indian investors can start investing in Atyr Pharma Inc (ATYR) shares with as little as ₹88.141 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Atyr Pharma Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Atyr Pharma Inc share’s latest price of $1.01 as on September 16, 2025 at 1:29 am IST, you will get 9.9010 shares of Atyr Pharma Inc. Learn more about fractional shares .